活动义齿

Search documents
“卷”不死的牙科 又要上市了
Sou Hu Cai Jing· 2025-09-25 09:42
9月19日,全国股转公司发布了《关于同意深圳康泰健医疗科技股份有限公司股票公开转让并在全国股转系统挂牌的函》,对深圳康泰健医疗科技股 份有限公司日期提出的公司股票在全国中小企业股份转让系统公开转让并挂牌的申请进行审核后同意通过。该函的有效期为自出具之日的12个月, 全国股转公司要求康泰健在有效期内按照有关规定完成挂牌。目前康泰健公司已经获批新三板股票代码:874918.NQ,若能够顺利上市,康泰健公 司将于新三板基础层挂牌。 图源:全国股转公司 6月27日,康泰健披露了公开转让说明书和公司股票在全国中小企业股份转让系统挂牌的申请。据悉,康泰健本次挂牌股份总量为44,215,000股,拟 于新三板基础层挂牌,主办券商为申万宏源承销保荐。同时康泰健相关律师事务所和主办券商也发布了相关的法律意见书和推荐报告,标志着康泰 健正式开启上市之路。 图源:深圳康泰健医疗科技股份有限公司 01|三个月内光速上市? 公开资料显示,深圳康泰健医疗科技股份有限公司成立于2003年,持续发展历史可追溯至1996年。曾用名为深圳市康泰健牙科器材有限公司,于 2022年12月变更为深圳康泰健医疗科技股份有限公司,沿用至今。 公司主要从事 ...
佳兆业健康发布中期业绩,股东应占亏损912.5万港元,同比收窄62.4%
Zhi Tong Cai Jing· 2025-08-27 14:44
Core Insights - Kaisa Health (00876) reported a mid-year performance for 2025 with revenue of HKD 69.577 million, a year-on-year decrease of 21.4% [1] - The company recorded a loss attributable to equity holders of HKD 9.125 million, a reduction of 62.4% compared to the previous period [1] - Basic loss per share was HKD 0.18 [1] Revenue Performance - The decline in revenue is primarily attributed to the Chinese government's centralized procurement price policy, which includes setting price ceilings for dental products sold domestically, leading to a decrease in average selling prices for dental products [1] Product Development and Strategy - The company adheres to the aesthetic restoration philosophy of "minimally invasive without harming teeth," aiming to reduce patient discomfort during cosmetic dental procedures [1] - In 2019, the company launched a series of digital dental products, including Meijia veneers XS, Meijia 3D simulated zirconia, Meijia transparent aligners, and removable dentures, which have received significant recognition from overseas technicians and dentists [1] Operational Expansion - To enhance product and service delivery, the company plans to establish regional manufacturing centers in cities such as Shanghai and Chengdu this year, aiming to reduce logistics costs and better serve local customers [1] - As of June 2025, the Hejia Rehabilitation Clinic has met all performance assessment criteria set by the Shenzhen Municipal Medical Insurance Bureau for designated medical insurance institutions, successfully entering the renewal phase [1] - The Hejia Rehabilitation Clinic experienced a 15% year-on-year increase in operating revenue following team expansion during the first half of the year [1]
佳兆业健康(00876)发布中期业绩,股东应占亏损912.5万港元,同比收窄62.4%
智通财经网· 2025-08-27 14:43
Core Viewpoint - Kaisa Health (00876) reported a decline in revenue and a narrowed loss for the first half of 2025, primarily due to the adverse effects of China's centralized procurement price policy on dental product pricing [1] Financial Performance - Revenue for the first half of 2025 was HKD 69.577 million, a decrease of 21.4% year-on-year [1] - Loss attributable to equity holders was HKD 9.125 million, a reduction of 62.4% year-on-year [1] - Basic loss per share was HKD 0.18 [1] Market and Product Development - The decline in revenue was mainly due to the Chinese government's price ceiling on dental products, which led to a decrease in average selling prices [1] - The company maintains a research and development focus on "minimally invasive aesthetic restoration," aiming to reduce patient discomfort during cosmetic dental procedures [1] - Kaisa Health plans to establish regional manufacturing centers in cities like Shanghai and Chengdu to lower logistics costs and enhance local service [1] Operational Updates - As of June 2025, Kaisa Rehabilitation Clinic met the periodic performance assessment criteria set by the Shenzhen Municipal Medical Insurance Bureau, successfully renewing its qualification as a designated medical insurance institution [1] - Approximately 2%-5% of institutions lost their medical insurance designation due to failing assessments [1] - The Kaisa Rehabilitation Clinic expanded its team, resulting in a 15% year-on-year increase in operating revenue [1]